Determination of Moxonidine and Its Impurities by Thin-Layer Chromatography

References

• Martindale: The complete drug reference, 36th ed.; Pharmaceutical Press: London, 2009; 1345 p.
   Google Scholar
• Fenton, C.; Keating, G. M.; Lyseng-Williamson, A. K. Moxonidine. A Review of Its Use in Essential Hypertension. Drugs. 2006, 66, 477–496.
   PubMed Web of Science ®Google Scholar
• Remko, M.; Swart, M.; Bickelhaupt, F. M. Theoretical Study of Structure, pKa, Lipophilicity, Solubility, Absorption and Polar Surface Area of Some Centrally Acting Antihypertensives. Bioorg. Med. Chem. 2006, 14, 1715–1728.
   PubMed Web of Science ®Google Scholar
• Nikolic, K.; Filipic, S.; Smoliński, A.; Kaliszan, R.; Agbaba, D. Partial Least Square and Hierarchical Clustering in ADMET Modeling: Prediction of Blood – Brain Barrier Permeation of α-Adrenergic and Imidazoline Receptor Ligands. J. Pharm. Pharm. Sci. 2013, 16, 622–647.
   PubMed Web of Science ®Google Scholar
• Wiczling, P.; Nasal, A.; Kubic, L.; Kaliszan, R. A New pH/organic Modifier Gradient RP HPLC Method for Convenient Determination of Lipophilicity and Acidity of Drugs as Applied to Established Imidazoline Agents. Eur. J. Pharm. Sci. 2012, 47, 1–5.
   PubMed Web of Science ®Google Scholar
• Shenger, M. S. M.; Filipic, S.; Nikolic, K.; Agbaba, D. Estimation of Lipophilicity and Retention Behavior of Some Alpha Adrenergic and Imidazoline Receptor Ligands Using RP-TLC. J. Liq. Chromatogr. Relat. Technol. 2014, 37, 2829–2845.
   Web of Science ®Google Scholar
• Erić, S.; Pavlović, M.; Popović, G.; Agbaba, D. Study of Retention Parameters Obtained in RP-TLC System and Their Application on QSAR/QSPR of Some Alpha Adrenergic and Imidazoline Receptor Ligands. J. Chromatogr. Sci. 2007, 45, 140–145.
   PubMed Web of Science ®Google Scholar
• Zhao, L.; Din, L.; Wei, X. Determination of Moxonidine in Human Plasma by Liquid Chromatography-Electrospray Ionization-Mass Spectrometry. J. Pharm. Biomed. Anal. 2006, 40, 95–99.
   PubMed Web of Science ®Google Scholar
• Rudolph, W.; Janssen, W.; Strassner, M. Determination of Moxonidine (BDF 5895) in Plasma by Gas Chromatography-Negative Ion Chemical Ionization Mass Spectrometry. J. Pharm. Biomed. Anal. 1992, 10, 323–328.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia, 8th ed.; Council of Europe: Strasbourg, France, 2014.
   Google Scholar
• British Pharmacopoeia, British Pharmacopoeia Commission. The Stationery Office (TSO): London, United Kingdom, 2011.
   Google Scholar
• Milovanović, S.; Otašević, B.; Zečević, M.; Živanvić, Lj.; Protić, A. Development and Validation of Reversed Phase High Performance Liquid Chromatographic Method for Determination of Moxonidine in the Presence of Its Impurities. J. Pharm. Biomed. Anal. 2012, 59, 151–168.
   PubMed Web of Science ®Google Scholar
• Otašević, B.; Milovanović, S.; Zečević, M.; Golubović, J.; Protić, A. UPLC Method for Determination of Moxonidine and Its Degradation Products in Active Pharmaceutical Ingredients and Pharmaceutical Dosage Forms. Chromatographia. 2014, 77, 109–118.
   Web of Science ®Google Scholar
• Olsen, B. Hydrophilic Interaction Chromatography Using Amino and Silica columns for the Determination of Polar Pharmaceuticals and Impurities. J. Chromatogr. A. 2001, 913, 113–122.
   PubMed Web of Science ®Google Scholar
• Mêlnický, R.; Kvapil, L.; Grepl, M.; Hradil, P. Formation and Various Mutual Transformations of Moxonidine. Acta Universitatis Palackianae Olomucensis, Facultas Rerum Naturalium Chemica. 2007, 46, 45–50.
   Google Scholar
• Kakde, R.; Gadpayale, K.; Qureshi, M. O. Stability Indicating HPTLC Method for Determination of Moxonidine in Pharmaceutical Preparations. Int. J. Pharm. Tech. Res. 2012, 4, 358–363.
   Google Scholar
• Renger, B.; Végh, Z.; Ferenczi-Fodor, K. Validation of Thin Layer and High Performance Thin Layer Chromatographic Methods. J. Chromatogr. A. 2011, 1218, 2712–2721.
   PubMed Web of Science ®Google Scholar
• Ferenczi-Fodor, K.; Végh, Z.; Renger, B. Thin Layer Chromatography in Testing the Purity of Pharmaceuticals. TRAC 2006, 25, 778–789.
   Web of Science ®Google Scholar